$791 Million is the total value of GREAT POINT PARTNERS LLC's 42 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 73.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $61,512,000 | +1.0% | 7,622,256 | -4.5% | 7.78% | -18.0% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $49,271,000 | +25.3% | 5,567,348 | +59.2% | 6.23% | +1.6% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INC | $48,439,000 | – | 1,180,000 | +100.0% | 6.12% | – |
| XLRN | Buy | ACCELERON PHARMA INC | $45,143,000 | -14.1% | 1,036,575 | +12.9% | 5.71% | -30.3% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $44,504,000 | +79.2% | 2,752,256 | +130.1% | 5.62% | +45.3% |
| PTCT | Buy | PTC THERAPEUTICS INC | $42,042,000 | +24.7% | 1,225,000 | +70.7% | 5.31% | +1.1% |
| KURA | Buy | KURA ONCOLOGY INC | $38,884,000 | +4.9% | 2,769,527 | +30.7% | 4.92% | -15.0% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $38,202,000 | -0.4% | 350,800 | +16.9% | 4.83% | -19.3% |
| ZGNX | New | ZOGENIX INC | $36,460,000 | – | 1,000,000 | +100.0% | 4.61% | – |
| BOLD | New | AUDENTES THERAPEUTICS INC | $35,346,000 | – | 1,657,873 | +100.0% | 4.47% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INCput | $33,142,000 | – | 200,000 | +100.0% | 4.19% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $28,077,000 | – | 1,379,700 | +100.0% | 3.55% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $26,363,000 | – | 1,850,000 | +100.0% | 3.33% | – |
| ONCE | Buy | SPARK THERAPEUTICS INC | $24,682,000 | +15.1% | 630,600 | +60.4% | 3.12% | -6.6% |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $22,305,000 | -2.8% | 2,398,409 | +45.6% | 2.82% | -21.1% |
| ICPT | New | INTERCEPT PHARMACEUTICALS INCput | $20,158,000 | – | 200,000 | +100.0% | 2.55% | – |
| CYTK | Buy | CYTOKINETICS INC | $20,055,000 | -6.6% | 3,173,288 | +45.6% | 2.54% | -24.2% |
| ZFGN | Buy | ZAFGEN INC | $17,812,000 | -55.1% | 3,598,392 | +6.1% | 2.25% | -63.6% |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $14,531,000 | -37.1% | 4,047,561 | +0.4% | 1.84% | -49.0% |
| SVRA | Sell | SAVARA INC CMN | $13,771,000 | -45.0% | 1,819,195 | -18.9% | 1.74% | -55.4% |
| TGTX | Buy | TG THERAPEUTICS INC | $12,300,000 | +12.6% | 3,000,000 | +53.8% | 1.56% | -8.6% |
| OSMT | New | OSMOTICA PHARMACEUTICALS PLC | $11,625,000 | – | 1,500,000 | +100.0% | 1.47% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $11,164,000 | – | 1,418,489 | +100.0% | 1.41% | – |
| MLND | New | MILLENDO THERAPEUTICS INC | $10,240,000 | – | 1,288,093 | +100.0% | 1.29% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $10,226,000 | – | 492,100 | +100.0% | 1.29% | – |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $10,163,000 | -43.5% | 143,481 | -31.8% | 1.28% | -54.1% |
| AMAG | New | AMAG PHARMACEUTICALS INC | $10,097,000 | – | 664,681 | +100.0% | 1.28% | – |
| PTI | New | PROTEOSTASIS THERAPEUTICS INC | $9,867,000 | – | 3,045,423 | +100.0% | 1.25% | – |
| MNLO | Buy | MENLO THERAPEUTICS INC | $9,082,000 | -29.3% | 2,204,407 | +69.0% | 1.15% | -42.7% |
| NVAX | New | NOVAVAX INCcall | $8,280,000 | – | 4,500,000 | +100.0% | 1.05% | – |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $6,431,000 | -36.4% | 955,618 | -2.7% | 0.81% | -48.4% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INCput | $4,556,000 | +5.0% | 400,000 | +100.0% | 0.58% | -14.8% |
| VYGR | Sell | VOYAGER THERAPEUTICS INC | $3,432,000 | -87.0% | 365,132 | -73.9% | 0.43% | -89.5% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $3,100,000 | -64.2% | 27,500 | -31.9% | 0.39% | -70.9% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $2,931,000 | -88.8% | 40,197 | -86.6% | 0.37% | -91.0% |
| SAGE | New | SAGE THERAPEUTICS INCcall | $2,491,000 | – | 26,000 | +100.0% | 0.32% | – |
| SAGE | New | SAGE THERAPEUTICS INCput | $2,491,000 | – | 26,000 | +100.0% | 0.32% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $1,777,000 | -81.8% | 18,500 | -85.7% | 0.22% | -85.2% |
| SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $132,000 | -93.4% | 317,962 | -68.2% | 0.02% | -94.6% |
| STRM | STREAMLINE HEALTH SOLUTIONS | $105,000 | -31.4% | 130,137 | 0.0% | 0.01% | -45.8% | |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -21,441 | -100.0% | -0.01% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -490,843 | -100.0% | -0.13% | – |
| ACER | Exit | ACER THERAPEUTICS INC | $0 | – | -58,461 | -100.0% | -0.28% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -241,970 | -100.0% | -0.59% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -1,606,100 | -100.0% | -4.44% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -2,075,000 | -100.0% | -5.73% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTNS, INC CMN | 25 | Q3 2019 | 2.5% |
| IOVANCE BIOTHERAPEUTICS, INC. CMN | 16 | Q1 2021 | 14.3% |
| ZOGENIX INC CMN | 16 | Q4 2019 | 8.8% |
| PTC THERAPEUTICS, INC. CMN | 16 | Q3 2023 | 9.9% |
| EXELIXIS, INC | 16 | Q1 2022 | 7.5% |
| SAGE THERAPEUTICS, INC CMN | 15 | Q3 2021 | 10.8% |
| CYTOKINETICS INC | 15 | Q3 2023 | 5.8% |
| ACADIA PHARMACEUTICALS, INC. | 14 | Q1 2021 | 8.8% |
| ACCELERON PHARMA INC CMN | 14 | Q2 2020 | 8.2% |
| CONNECTURE INC | 13 | Q4 2017 | 25.1% |
View GREAT POINT PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 89bio, Inc. | February 14, 2023 | 700,000 | 1.4% |
| KalVista Pharmaceuticals, Inc. | February 14, 2023 | 1,055,801 | 3.1% |
| Avalo Therapeutics, Inc. | February 13, 2023 | 974,639 | 7.1% |
| InflaRx N.V.Sold out | February 14, 2022 | 0 | 0.0% |
| ABEONA THERAPEUTICS INC.Sold out | February 16, 2021 | 0 | 0.0% |
| CONSTELLATION PHARMACEUTICALS INC | February 16, 2021 | 1,024,800 | 2.2% |
| GERON CORP | February 16, 2021 | 12,754,228 | 4.0% |
| Millendo Therapeutics, Inc. | February 16, 2021 | 270,000 | 1.4% |
| NextCure, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | February 16, 2021 | 977,647 | 2.4% |
View GREAT POINT PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View GREAT POINT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.